Trial CTSU/NSABP-B43

A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In-Situ Resected by Lumpectomy.

Type: Cancer Therapy
Phase: Phase III
Status: Open to Accrual
Treatments: Immunotherapy, Radiation: External
Randomized: Yes
Defintions of terms and FAQ about clinical trials.

Trial Leaders/Researchers: Eugene Chung, M.D.
Other Trial Staff: Kristy Watkins, R.N., Jessica Levano, R.N., Shamim Jhimlee, D.M., Cynthia Estrada, R.N., Amanda Luna, D.M.

Staff may log in to see study documents.

For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.